Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AKU NASDAQ:BDSX NASDAQ:ONC NASDAQ:PRN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAKUAkumin$0.18$0.12▼$1.90$26.32M-0.721.38 million shs8.54 million shsBDSXBiodesix$0.31+1.0%$0.31$0.17▼$2.04$45.23M0.972.48 million shs456,272 shsONCBeOne Medicines$250.30-1.2%$247.19$146.21▼$287.88$27.43B0.28302,202 shs371,565 shsPRNInvesco Dorsey Wright Industrials Momentum ETF$156.56+0.3%$150.40$118.25▼$180.08$352.26M1.0744,513 shs10,386 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAKUAkumin0.00%0.00%0.00%0.00%0.00%BDSXBiodesix0.00%+11.81%+2.90%-41.77%-80.95%ONCBeOne Medicines0.00%+1.96%-9.49%+8.66%+25,029,999,900.00%PRNInvesco Dorsey Wright Industrials Momentum ETF0.00%-0.66%+2.82%+18.18%+15.39%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAKUAkuminN/AN/AN/AN/AN/AN/AN/AN/ABDSXBiodesix4.0973 of 5 stars4.45.00.00.02.72.50.6ONCBeOne Medicines3.4384 of 5 stars4.50.00.00.03.01.70.6PRNInvesco Dorsey Wright Industrials Momentum ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAKUAkumin 0.00N/AN/AN/ABDSXBiodesix 2.80Moderate Buy$1.75467.08% UpsideONCBeOne Medicines 3.00Buy$320.6728.11% UpsidePRNInvesco Dorsey Wright Industrials Momentum ETF 2.64Moderate Buy$156.56N/ACurrent Analyst Ratings BreakdownLatest AKU, ONC, YGEN, BDSX, and PRN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/27/2025ONCBeOne MedicinesMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$313.00 ➝ $330.006/27/2025ONCBeOne MedicinesJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$317.00 ➝ $321.006/27/2025ONCBeOne MedicinesRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeOutperform ➝ Moderate Buy$311.005/21/2025BDSXBiodesixScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSector Outperform ➝ Sector Outperform$3.00 ➝ $2.005/14/2025BDSXBiodesixLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$3.00 ➝ $2.005/14/2025BDSXBiodesixCraig HallumSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$3.00 ➝ $1.505/14/2025BDSXBiodesixCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$2.50 ➝ $1.505/14/2025BDSXBiodesixWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Market Perform5/8/2025ONCBeOne MedicinesRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$312.00 ➝ $311.005/8/2025ONCBeOne MedicinesGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$348.00 ➝ $350.004/29/2025BDSXBiodesixCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$3.50 ➝ $2.50(Data available from 7/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAKUAkumin$749.63M0.00N/AN/A$1.24 per share0.00BDSXBiodesix$71.32M0.63N/AN/A$0.14 per share2.20ONCBeOne Medicines$3.81B7.20N/AN/A$34.10 per share7.34PRNInvesco Dorsey Wright Industrials Momentum ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAKUAkumin-$156.76M-$2.52N/AN/AN/A-30.56%-167.86%-7.81%N/ABDSXBiodesix-$42.93M-$0.29N/AN/AN/A-54.28%-167.28%-39.96%8/6/2025 (Estimated)ONCBeOne Medicines-$644.79M-$3.72N/A352.54N/A-9.40%-7.55%-4.42%N/APRNInvesco Dorsey Wright Industrials Momentum ETFN/AN/A28.33∞N/AN/AN/AN/AN/ALatest AKU, ONC, YGEN, BDSX, and PRN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2025Q2 2025BDSXBiodesix-$0.07N/AN/AN/A$18.47 millionN/A5/13/2025Q1 2025BDSXBiodesix-$0.08-$0.08N/A-$0.08$19.50 million$17.96 million5/7/2025Q1 2025ONCBeOne Medicines-$0.71$1.22+$1.93$0.01$1.12 billion$1.12 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAKUAkuminN/AN/AN/AN/AN/ABDSXBiodesixN/AN/AN/AN/AN/AONCBeOne MedicinesN/AN/AN/AN/AN/APRNInvesco Dorsey Wright Industrials Momentum ETF$0.570.36%N/AN/AN/ALatest AKU, ONC, YGEN, BDSX, and PRN DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/23/2025PRNInvesco Dorsey Wright Industrials Momentum ETFQuarterly$0.07180.19%6/23/20256/23/20256/27/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAKUAkumin17.020.990.99BDSXBiodesix3.322.222.22ONCBeOne Medicines0.051.961.71PRNInvesco Dorsey Wright Industrials Momentum ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAKUAkumin36.10%BDSXBiodesix20.96%ONCBeOne Medicines48.55%PRNInvesco Dorsey Wright Industrials Momentum ETFN/AInsider OwnershipCompanyInsider OwnershipAKUAkumin20.51%BDSXBiodesix30.10%ONCBeOne Medicines6.62%PRNInvesco Dorsey Wright Industrials Momentum ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAKUAkumin3,63191.17 million72.47 millionNot OptionableBDSXBiodesix220146.56 million102.45 millionOptionableONCBeOne Medicines11,000109.60 million102.34 millionN/APRNInvesco Dorsey Wright Industrials Momentum ETFN/A2.25 millionN/AOptionableAKU, ONC, YGEN, BDSX, and PRN HeadlinesRecent News About These CompaniesInvesco Dorsey Wright Industrials Momentum ETF Experiences Big ... - NasdaqJuly 12 at 2:37 AM | nasdaq.comShould You Invest in the Invesco Dorsey Wright Industrials Momentum ETF (PRN)?June 5, 2025 | zacks.comShould You Invest in the Invesco Dorsey Wright Industrials Momentum ETF (PRN)?March 31, 2025 | zacks.comPRN: Better Than XLI On Some Fronts, But Still A Questionable BuyMarch 7, 2025 | seekingalpha.comPDP: Challenging Times For This Momentum-Focused ETFFebruary 11, 2025 | seekingalpha.comShould You Invest in the Invesco Dorsey Wright Industrials Momentum ETF (PRN)?January 27, 2025 | zacks.com5 Top-Ranked ETFs to Buy CheapJanuary 9, 2025 | zacks.comUnwrapping 5 ETF Surprises From Secret Santa for ChristmasDecember 20, 2024 | zacks.comPRN: Industrials Dashboard For DecemberDecember 16, 2024 | seekingalpha.comInvesco's 5 Top-Performing ETFs in 2024November 26, 2024 | etftrends.comEShould You Invest in the Invesco Dorsey Wright Industrials Momentum ETF (PRN)?November 25, 2024 | zacks.comInvesco Dorsey Wright Industrials Momentum ETF (PRN)November 21, 2024 | ca.finance.yahoo.comInvesco Dorsey Wright Developed Markets Momentum ETF (PIZ)September 28, 2024 | finance.yahoo.comInvesco DWA Industrials Momentum ETF declares quarterly distribution of $0.2432September 24, 2024 | msn.comShould You Invest in the Invesco Dorsey Wright Industrials Momentum ETF (PRN)?September 23, 2024 | zacks.comWhen (PRN) Moves Investors should ListenSeptember 21, 2024 | news.stocktradersdaily.comNShould You Invest in the Invesco Dorsey Wright Industrials Momentum ETF (PRN)?July 24, 2024 | zacks.comTrading (PRN) With Integrated Risk ControlsJuly 24, 2024 | news.stocktradersdaily.comNShould You Invest in the Invesco Dorsey Wright Industrials Momentum ETF (PRN)?May 23, 2024 | zacks.comInvesco Industrials S&P US Select Sector UCITS ETF (XLIS.SW)May 16, 2024 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir SoonD-Wave Is Rising Again Despite Dilution—What’s the Deal?By Nathan Reiff | July 7, 2025View D-Wave Is Rising Again Despite Dilution—What’s the Deal?These 3 Dividend Stocks Are Not Concerned With Tariff NoiseBy Thomas Hughes | July 11, 2025View These 3 Dividend Stocks Are Not Concerned With Tariff NoiseIGM ETF: Expand Tech Exposure With Top AI LeadersBy Jeffrey Neal Johnson | July 1, 2025View IGM ETF: Expand Tech Exposure With Top AI LeadersMarketBeat Week in Review – 07/07 - 07/11By MarketBeat Staff | July 12, 2025View MarketBeat Week in Review – 07/07 - 07/11AKU, ONC, YGEN, BDSX, and PRN Company DescriptionsAkumin NASDAQ:AKUAkumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other diagnostic and interventional radiology procedures through owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to hospitals and health systems across 48 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida.Biodesix NASDAQ:BDSX$0.31 +0.00 (+1.05%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$0.30 -0.01 (-2.46%) As of 07/11/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.BeOne Medicines NASDAQ:ONC$250.30 -3.09 (-1.22%) As of 07/11/2025 04:00 PM EasternBeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.Invesco Dorsey Wright Industrials Momentum ETF NASDAQ:PRN$156.56 +0.47 (+0.30%) Closing price 07/11/2025 03:59 PM EasternExtended Trading$156.62 +0.06 (+0.04%) As of 07/11/2025 04:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PowerShares Dynamic Industrials Sector Portfolio (the Fund) seeks investment results that correspond generally to the price and yield of the Dynamic Industrials Sector Intellidex Index (the Index). The Index consists of stocks of 60 United States industrial companies. These are companies that are principally engaged in the business of providing industrial products and services, including engineering, heavy machinery, construction, electrical equipment, aerospace and defense, and general manufacturing. The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/07 - 07/11 Power Solutions International Poised for 75% Upside The Meteoric Rise of Rocket Lab: A Space Stock to Watch Meta and Autonomous Advertising: The Stock's Next Big Tailwind? Super Micro Computer: The Hidden Winner of Soaring Copper Tariffs Nebius Group: Up 385%, Analysts Say It’s Still a Bargain Conagra at Rock Bottom: 7% Yield & Turnaround Poised Delta Air Lines Could Reach New Highs in 2025—And Here’s Why Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
